Stay updated on TransCon IL-2 β/γ Clinical Trial
Sign up to get notified when there's something new on the TransCon IL-2 β/γ Clinical Trial page.

Latest updates to the TransCon IL-2 β/γ Clinical Trial page
- CheckyesterdayChange DetectedThe footer now identifies the ClinicalTrials.gov site as revision v3.8.1 instead of v3.8.0.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe footer's ClinicalTrials.gov release identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check29 days agoChange DetectedA sitewide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” was added, and the footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.6%

- Check36 days agoChange DetectedThe record history now reflects a study-status update submitted October 9 and posted October 13, 2026.SummaryDifference0.3%

- Check43 days agoChange DetectedThe ClinicalTrials.gov footer revision number changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check64 days agoChange DetectedThe history now includes a new 'Study Status' entry and the latest site revision (v3.7.0) is recorded. An older revision entry (v3.6.6) was removed from the history.SummaryDifference0.4%

Stay in the know with updates to TransCon IL-2 β/γ Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TransCon IL-2 β/γ Clinical Trial page.